Cancer

As the immune system ages, our susceptibility to conditions such as cancer increases, prompting researchers to develop advanced experimental models to study these pathways.

Researchers find that targeting nerve growth factor in melanomas transforms resistant ‘cold’ tumours into treatable ‘hot’ ones, adding new therapeutic options for challenging skin cancers.

A*STAR researchers developed specially designed nanocomplexes that effectively target and kill cancer cells, including those resistant to traditional treatments.

Researchers develop a new technology for studying how brain tumours interact with the blood-brain barrier to inform future treatment strategies.

Researchers identify predictive immune ‘signatures’ in liver cancer patients that can help tailor and improve the success rates of combined immunotherapy and radiotherapy.

Researchers reveal how disrupting a key genetic control mechanism can significantly hinder the progression and spread of an aggressive and difficult-to-treat form of breast cancer.

Unique gene signatures associated with drug-resistant leukaemia paves the way for improved clinical strategies to help these patients.

Researchers develop a protocol to boost the effectiveness of and reduce the risk of potential side effects for T cell cancer therapies.

Researchers have discovered a molecular pathway in colorectal cancer cells that leads to uncontrolled division, creating an avenue for more targeted therapies.

A new diagnostic innovation powered by artificial intelligence could empower surgeons to make more accurate and effective clinical decisions for colon cancer patients.

A T cell therapy innovation may offer new hope for acute myeloid leukemia patients who relapse after conventional treatment.

A*STAR researchers discover a mechanism that fires up the metabolism of cancer-killing immune cells, paving the way for future cancer immunotherapies.